š° ZLAB Latest News
Last Updated: 2026.05.11 04:02:08
Recent Headlines
Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)
BusinessWire
2026-05-11 4:02 AM
Zai Lab Q1 Earnings Call Highlights
MarketBeat
2026-05-09 9:05 AM
Zai Lab Limited (ZLAB) Q1 2026 Earnings Call Transcript
SeekingAlpha
2026-05-08 2:41 AM
Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates
BusinessWire
2026-05-07 10:00 AM
Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates
BusinessWire
2026-05-07 10:00 AM
Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases - Slideshow
SeekingAlpha
2026-04-22 11:13 PM
Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026
BusinessWire
2026-04-22 11:30 AM
Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases Transcript
SeekingAlpha
2026-04-20 11:11 PM
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31RĪ± Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases
BusinessWire
2026-04-18 1:00 PM
Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas
BusinessWire
2026-04-17 7:01 PM
Zai Lab Limited 2025 Q4 - Results - Earnings Call Presentation
SeekingAlpha
2026-02-27 10:00 PM
Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript
SeekingAlpha
2026-02-26 6:47 PM
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
BusinessWire
2026-02-26 12:00 PM
š®
Keep Stock Illuminati Free
100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.
Donate via PayPal
One-time or recurring ā every dollar helps us add more data & features.